These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3137385)

  • 1. Chronopharmacological study of sodium valproate in mice: dose-concentration-response relationship.
    Ohdo S; Nakano S; Ogawa N
    Jpn J Pharmacol; 1988 May; 47(1):11-9. PubMed ID: 3137385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronotoxicity of sodium valproate and its mechanisms in mice: dose-concentration-response relationship.
    Ohdo S; Nakano S; Ogawa N
    Chronobiol Int; 1989; 6(3):229-35. PubMed ID: 2509086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronopharmacological study of valproic acid in mice: comparison of oral and rectal administration.
    Yoshiyama Y; Nakano S; Ohdo S; Ogawa N
    J Pharmacobiodyn; 1992 Aug; 15(8):403-8. PubMed ID: 1479540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of feeding schedule on the chronopharmacological aspects of sodium valproate in mice.
    Ohdo S; Ogawa N; Nakano S; Higuchi S
    J Pharmacol Exp Ther; 1996 Jul; 278(1):74-81. PubMed ID: 8764337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronotoxicity of sodium valproate in pregnant mouse and embryo.
    Ohdo S; Watanabe H; Ogawa N; Yoshiyama Y; Sugiyama T
    Jpn J Pharmacol; 1996 Mar; 70(3):253-8. PubMed ID: 8935719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circadian variation in anticonvulsant activity of valproic acid in mice.
    Khedhaier WBC; Dridi I; Aouam K; Ben-Attia M; Reinberg A; Boughattas NA
    Biomed Pharmacother; 2017 Nov; 95():25-30. PubMed ID: 28826093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circadian rhythm of embryotoxicity induced by sodium valproate in mice.
    Ohdo S; Watanabe H; Ogawa N; Yoshiyama Y; Sugiyama T
    Eur J Pharmacol; 1995 Oct; 293(3):281-5. PubMed ID: 8666048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronopharmacokinetics of valproic acid following constant-rate administration in mice.
    Ohdo S; Nakano S; Ogawa N
    Chronobiol Int; 1991 Feb; 8(1):35-43. PubMed ID: 1814601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circadian variation of Valproic acid pharmacokinetics in mice.
    Ben-Cherif W; Dridi I; Aouam K; Ben-Attia M; Reinberg A; Boughattas NA
    Eur J Pharm Sci; 2013 Jul; 49(4):468-73. PubMed ID: 23707469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valproic acid phase shifts the rhythmic expression of Period2::Luciferase.
    Johansson AS; Brask J; Owe-Larsson B; Hetta J; Lundkvist GB
    J Biol Rhythms; 2011 Dec; 26(6):541-51. PubMed ID: 22215612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Circadian rhythms of toxicity and pharmacokinetics of gentamicin in mice].
    Song JG
    Yao Xue Xue Bao; 1991; 26(6):401-5. PubMed ID: 1789104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticonvulsant profile of caprylic acid, a main constituent of the medium-chain triglyceride (MCT) ketogenic diet, in mice.
    Wlaź P; Socała K; Nieoczym D; Łuszczki JJ; Zarnowska I; Zarnowski T; Czuczwar SJ; Gasior M
    Neuropharmacology; 2012 Mar; 62(4):1882-9. PubMed ID: 22210332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valproic acid disrupts the oscillatory expression of core circadian rhythm transcription factors.
    Griggs CA; Malm SW; Jaime-Frias R; Smith CL
    Toxicol Appl Pharmacol; 2018 Jan; 339():110-120. PubMed ID: 29229235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Furosemide potentiates the anticonvulsant action of valproate in the mouse maximal electroshock seizure model.
    Luszczki JJ; Sawicka KM; Kozinska J; Borowicz KK; Czuczwar SJ
    Epilepsy Res; 2007 Aug; 76(1):66-72. PubMed ID: 17659862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-phosphonomethyl-pentanedioic acid (glutamate carboxypeptidase II inhibitor) increases threshold for electroconvulsions and enhances the antiseizure action of valproate against maximal electroshock-induced seizures in mice.
    Luszczki JJ; Mohamed M; Czuczwar SJ
    Eur J Pharmacol; 2006 Feb; 531(1-3):66-73. PubMed ID: 16403497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1-Methyl-1,2,3,4-tetrahydroisoquinoline enhances the anticonvulsant action of carbamazepine and valproate in the mouse maximal electroshock seizure model.
    Luszczki JJ; Antkiewicz-Michaluk L; Czuczwar SJ
    Neuropharmacology; 2006 Feb; 50(2):133-42. PubMed ID: 16153667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modafinil and its metabolites enhance the anticonvulsant action of classical antiepileptic drugs in the mouse maximal electroshock-induced seizure model.
    Zolkowska D; Andres-Mach M; Prisinzano TE; Baumann MH; Luszczki JJ
    Psychopharmacology (Berl); 2015 Jul; 232(14):2463-79. PubMed ID: 25697861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arachidonyl-2'-chloroethylamide, a highly selective cannabinoid CB1 receptor agonist, enhances the anticonvulsant action of valproate in the mouse maximal electroshock-induced seizure model.
    Luszczki JJ; Czuczwar P; Cioczek-Czuczwar A; Czuczwar SJ
    Eur J Pharmacol; 2006 Oct; 547(1-3):65-74. PubMed ID: 16930590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of sodium valproate and its metabolites (5-OH-VPA and 4-OH-VPA) on electroconvulsions in rats.
    Sobaniec W; Sobaniec-Lotowska M
    Mater Med Pol; 1994; 26(1):29-32. PubMed ID: 7808038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of feeding schedule on chronopharmacological aspects of gentamicin in mice.
    Song J; Ohdo S; Ogawa N; Nakano S
    Chronobiol Int; 1993 Oct; 10(5):338-48. PubMed ID: 8261533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.